Singapore, April 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab A... Read More
Singapore, April 9 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Ret... Read More
Singapore, April 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination Wi... Read More
Singapore, April 9 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More
New Delhi, April 9 -- India is struggling to bridge a logistical gap that leaves its huge pharmaceutical industry reliant on imports for a key chemical, even as domestic capacity sits idle. While stat... Read More
Mumbai, April 9 -- The equity markets witnessed renewed selling pressure on Thursday, with both benchmark indices closing in the red amid rising uncertainty in the ongoing Middle East conflict. The N... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517211) titled 'A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517939) titled 'What Are the Predictors of Acute Kidney Injury in Children Admitted to Pediatrics Intensive... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516652) titled 'Prospective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release' on Ma... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518121) titled 'A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil' on March 26. Brief Sum... Read More